Microshunt PRESERFLO™ for microinvasive glaucoma surgery
Open Access
- 27 May 2025
- journal article
- Published by Research Institute of Eye Diseases in National Journal glaucoma
- Vol. 24 (2) , 61-72
Abstract
The current gold standard of glaucoma surgery is trabeculectomy, which allows sustained reduction of intraocular pressure (IOP). However, trabeculectomy is relatively traumatic and is associated with a risk of specific complications. As a result, a number of devices for microinvasive glaucoma surgery have been developed, designed to create a hypotensive effect comparable to trabeculectomy, coupled with minimal surgical trauma.Microshunt PRESERFLO™ (Santen) is a polymer microshunt that facilitats the outflow of aqueous humor into the subconjunctival space with the formation of a filtering bleb. It is implanted through a subconjunctival approach, typical for trabeculectomy, however, due to the controlled aqueous outflow it minimizes the risk of complications typical for glaucoma interventions.Long-term (up to 5 years) efficacy and safety of PRESERFLO™ microshunt implantation have been demonstrated in a number of studies, including those comparing PRESERFLO™ with other surgeries. Meta-analyses comparing PRESERFLO™ and trabeculectomy show comparable efficacy of the interventions with a lower risk of complications in PRESERFLO™. Studies comparing PRESERFLO™ with similarly designed microshunt XEN (Allergan, Plc, Ireland) show that PRESERFLO™ is either equally or more effective.Keywords
This publication has 59 references indexed in Scilit:
- One-Year Comparison of Efficacy and Safety of PreserFlo MicroShunt with Mitomycin C Applied by Sub-Tenon Injection Versus SpongeOphthalmology and Therapy, 2024
- PreserFlo MicroShunt versus trabeculectomy: an updated meta-analysis and systematic reviewGraefe's Archive for Clinical and Experimental Ophthalmology, 2024
- The use of intraluminal PRESERFLO stenting in avoiding early postoperative hypotonyGraefe's Archive for Clinical and Experimental Ophthalmology, 2024
- Intermediate-term impact on corneal endothelial cells and efficacy of Preserflo MicroShunt implantation in patients with open-angle glaucoma – a prospective study over two yearsGraefe's Archive for Clinical and Experimental Ophthalmology, 2024
- Histopathological findings of failed blebs after microinvasive bleb surgery with the XEN Gel Stent and Preserflo MicroShuntGraefe's Archive for Clinical and Experimental Ophthalmology, 2024
- Results of open bleb revision as management of primary bleb failure following XEN 45 gel stent and Preserflo™ MicroshuntGraefe's Archive for Clinical and Experimental Ophthalmology, 2023
- Systematic Literature Review of Clinical and Economic Outcomes of Micro-Invasive Glaucoma Surgery (MIGS) in Primary Open-Angle GlaucomaOphthalmology and Therapy, 2018
- The development of a micro‐shunt made from poly(styrene‐block‐isobutylene‐block‐styrene) to treat glaucomaJournal of Biomedical Materials Research Part B: Applied Biomaterials, 2015
- In vivo and in vitro characterization of poly(styrene‐b‐isobutylene‐b‐styrene) copolymer stent coatings for biostability, vascular compatibility and mechanical integrityJournal of Biomedical Materials Research Part A, 2009
- A Newly Designed Glaucoma Drainage Implant Made of Poly(styrene-b-isobutylene-b-styrene)Archives of Ophthalmology (1950), 2006